Literature DB >> 3674052

Isolated clinical syndrome of primary aldosteronism in four patients with adrenocortical carcinoma.

D Farge1, G Chatellier, J Y Pagny, X Jeunemaitre, P F Plouin, P Corvol.   

Abstract

Adrenocortical carcinoma is a rare disorder that can be revealed by an isolated syndrome of mineralocorticoid excess. In a retrospective study of 137 patients referred to our hypertension clinic in the past 10 years for primary aldosteronism, four cases of adrenocortical carcinoma were identified. The clinical presentation of these patients was similar to that of patients with Conn's adenoma, but preoperatively, malignant tumoral primary aldosteronism was suspected because of profound hypokalemia, marked elevation in plasma aldosterone levels, and enlarged size and weight of an heterogenous adrenal tumor with internal calcifications. Malignancy was confirmed by the histologic features. No prognostic criteria could be established and two patients died despite specific surgery, which was performed in all cases. More recent developments in the use of mitotane led to the addition of adrenocorticolytic therapy in the remaining two patients, who are still alive at the time of this report.

Entities:  

Mesh:

Year:  1987        PMID: 3674052     DOI: 10.1016/0002-9343(87)90891-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

Review 1.  Current perspective in the diagnosis and treatment of adrenocortical carcinoma.

Authors:  D E Schteingart
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Adrenocortical carcinoma producing 11-deoxycorticosterone: a rare cause of mineralocorticoid hypertension.

Authors:  K Müssig; M Wehrmann; M Horger; C Maser-Gluth; H U Häring; D Overkamp
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

3.  Adrenocortical carcinoma manifesting pure primary aldosteronism: a case report and analysis of steroidogenic enzymes.

Authors:  T Yoshimoto; M Naruse; Y Ito; K Naruse; T Ueda; A Tanabe; S Harada; T Nishikawa; H Sasano; T Obara; H Demura
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

Review 4.  Functional tests for primary aldosteronism: value of captopril suppression.

Authors:  Marie-Claude Racine; Pierre Douville; Marcel Lebel
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

Review 5.  Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension. A review of 30 cases.

Authors:  Brian K P Goh; Yeh-Hong Tan; Kenneth T E Chang; Peter H K Eng; Sidney K H Yip; Christopher W S Cheng
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

Review 6.  Genetic causes of primary aldosteronism.

Authors:  Eric Seidel; Julia Schewe; Ute I Scholl
Journal:  Exp Mol Med       Date:  2019-11-06       Impact factor: 8.718

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.